JP2016508969A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016508969A5 JP2016508969A5 JP2015548050A JP2015548050A JP2016508969A5 JP 2016508969 A5 JP2016508969 A5 JP 2016508969A5 JP 2015548050 A JP2015548050 A JP 2015548050A JP 2015548050 A JP2015548050 A JP 2015548050A JP 2016508969 A5 JP2016508969 A5 JP 2016508969A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- cancer
- alkyl
- patent document
- tumor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- LBNUURWIDGNVSU-UHFFFAOYSA-N CCCN(C(CN1C)=O)C1=O Chemical compound CCCN(C(CN1C)=O)C1=O LBNUURWIDGNVSU-UHFFFAOYSA-N 0.000 description 1
- WFLQKGQIUPCFDB-UHFFFAOYSA-N CCCN(C(CO1)=O)C1=O Chemical compound CCCN(C(CO1)=O)C1=O WFLQKGQIUPCFDB-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261737658P | 2012-12-14 | 2012-12-14 | |
| US61/737,658 | 2012-12-14 | ||
| PCT/US2013/075505 WO2014093988A2 (en) | 2012-12-14 | 2013-12-16 | Methods and compositions for inhibiting cnksr1 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016508969A JP2016508969A (ja) | 2016-03-24 |
| JP2016508969A5 true JP2016508969A5 (https=) | 2017-02-23 |
| JP6357292B2 JP6357292B2 (ja) | 2018-07-11 |
Family
ID=50935099
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015548050A Active JP6357292B2 (ja) | 2012-12-14 | 2013-12-16 | Ｃｎｋｓｒ１を阻害するための方法及び組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9340532B2 (https=) |
| EP (1) | EP2931280B1 (https=) |
| JP (1) | JP6357292B2 (https=) |
| AU (1) | AU2013358876B2 (https=) |
| CA (1) | CA2895162C (https=) |
| MX (2) | MX372739B (https=) |
| WO (1) | WO2014093988A2 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014093988A2 (en) | 2012-12-14 | 2014-06-19 | Phusis Therapeutics, Inc. | Methods and compositions for inhibiting cnksr1 |
| US10227356B2 (en) * | 2015-04-20 | 2019-03-12 | Phusis Therapeutics, Inc. | Compounds, compositions and methods for inhibiting CNKSR1 |
| WO2018125983A1 (en) | 2016-12-30 | 2018-07-05 | Mitobridge, Inc. | Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (acmsd) inhibitors |
| CN110698411B (zh) * | 2018-07-09 | 2023-05-09 | 四川大学 | 一类4-(胺烷基)酞嗪-1-酮类化合物、其制备方法和用途 |
| US20230312482A1 (en) * | 2020-07-28 | 2023-10-05 | Mirati Therapeutics, Inc. | Sos1 inhibitors |
| US20240158386A1 (en) * | 2021-03-02 | 2024-05-16 | Icahn School Of Medicine At Mount Sinai | Benzoxazolone inhibitors of inflammasomes |
| TW202319375A (zh) * | 2021-08-19 | 2023-05-16 | 美商安進公司 | 用於製備丙烯酸酯化合物之無鈀方法 |
| WO2024192873A1 (zh) * | 2023-03-20 | 2024-09-26 | 杭州天玑济世生物科技有限公司 | 一类具有萘胺结构的小分子化合物的用途 |
| CN116444477B (zh) * | 2023-04-04 | 2026-01-02 | 宁波九胜创新医药科技有限公司 | 一种溴代胡椒环羧酸的制备方法及其用途 |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA775563A (en) | 1968-01-09 | Frank W. Horner Limited | Hypoglycemic thiadiazoles | |
| GB828963A (en) | 1956-08-03 | 1960-02-24 | Rhone Poulenc Sa | Pharmaceutical compositions containing 2-p-aminobenzenesulphonamido-5-t-butyl-1, 3, 4-thiadiazole |
| US3821222A (en) | 1971-11-22 | 1974-06-28 | Chevron Res | Hydrocarbyl sulfenylmercapto pyrimidines |
| US4017489A (en) | 1975-07-10 | 1977-04-12 | The Goodyear Tire & Rubber Company | Process of preparing unsymmetrical disulfides |
| DE2556011A1 (de) | 1975-12-12 | 1977-06-23 | Merck Patent Gmbh | Disulfide |
| IE47592B1 (en) * | 1977-12-29 | 1984-05-02 | Ici Ltd | Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture |
| GB2152497B (en) | 1983-11-28 | 1987-08-05 | Otsuka Kagaku Kk | Process for the preparation of azetidinone derivatives |
| FR2573077B1 (fr) | 1984-11-13 | 1987-02-13 | Sanofi Sa | Nouveaux derives thiosulfonates, leur procede de preparation ainsi que les compositions pharmaceutiques les contenant |
| US4939140A (en) * | 1985-11-07 | 1990-07-03 | Pfizer Inc. | Heterocyclic oxophthalazinyl acetic acids |
| US4990523A (en) | 1989-06-19 | 1991-02-05 | A. H. Robins Company, Incorporated | Treatment of chronic inflammatory joint disease with arylsulfonamides |
| GB9507415D0 (en) * | 1994-06-08 | 1995-05-31 | Zylepsis Ltd | Production and uses of caffeic acid and derivatives thereof |
| US6139875A (en) | 1998-09-29 | 2000-10-31 | Eastman Chemical Company | Aqueous enteric coating composition and low gastric permeability enteric coating |
| FR2815032B1 (fr) | 2000-10-10 | 2003-08-08 | Pf Medicament | Nouveaux derives d'aminophenyle piperazine ou d'amino phenyle piperide inhibiteurs de proteines prenyl transferase ainsi que leurs preparations |
| US20040106540A1 (en) | 2001-04-10 | 2004-06-03 | Barnett Stanley F | Method of treating cancer |
| KR100955015B1 (ko) * | 2001-08-15 | 2010-04-28 | 이코스 코포레이션 | 2ｈ-프탈라진-1-온 및 이것의 사용 방법 |
| GB0205693D0 (en) | 2002-03-09 | 2002-04-24 | Astrazeneca Ab | Chemical compounds |
| EP1496981A2 (en) | 2002-04-08 | 2005-01-19 | Merck & Co., Inc. | Method of treating cancer |
| GB0215823D0 (en) * | 2002-07-09 | 2002-08-14 | Astrazeneca Ab | Quinazoline derivatives |
| US20040102360A1 (en) | 2002-10-30 | 2004-05-27 | Barnett Stanley F. | Combination therapy |
| DE602004032345D1 (de) | 2003-06-24 | 2011-06-01 | Isis Innovation | Reagenzien und verfahren zur bildung von disulfid-bindungen und glykosylierung von proteinen |
| JP2009513523A (ja) | 2003-07-08 | 2009-04-02 | ノバルティス アクチエンゲゼルシャフト | ベンゼンスルホニルアミノ化合物およびそれらを含む医薬組成物 |
| DE602005015838D1 (de) | 2004-03-19 | 2009-09-17 | Tapemark Co | Thermoplastische filme und herstellungsverfahren dafür |
| WO2005097758A1 (en) | 2004-03-26 | 2005-10-20 | Amphora Discovery Corporation | Certain triazole-based compounds, compositions, and uses thereof |
| SE0402635D0 (sv) | 2004-10-29 | 2004-10-29 | Astrazeneca Ab | Chemical compounds |
| DE102005011822A1 (de) * | 2005-03-15 | 2006-09-21 | Merck Patent Gmbh | Phthalazinone |
| EP1937659B1 (en) | 2005-10-06 | 2010-11-10 | Sanofi-Aventis | Cyclic n-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| US20070213378A1 (en) | 2006-03-10 | 2007-09-13 | Lymphosign Inc. | Compounds for modulating cell proliferation, compositions and methods related thereto |
| WO2007114926A2 (en) | 2006-04-04 | 2007-10-11 | The Regents Of The University Of California | Kinase antagonists |
| EP2104489A2 (en) | 2006-12-26 | 2009-09-30 | FemmePharma Holding Company, Inc. | Topical administration of danazol |
| MX2010011258A (es) | 2008-04-14 | 2011-06-20 | Univ Texas | Inhibidores de molecula pequeña del dominio de homologia de pleckstrin y metodos para usar los mismos. |
| WO2010085968A1 (en) * | 2008-12-30 | 2010-08-05 | European Molecular Biology Laboratory (Embl) | Toluidine sulfonamides and their use as hif-inhibitors |
| WO2010118063A2 (en) * | 2009-04-06 | 2010-10-14 | Agios Pharmaceuticals, Inc. | Therapeutic compositions and related methods of use |
| CA2773561A1 (en) * | 2009-09-14 | 2011-03-17 | Phusis Therapeutics Inc. | Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same |
| JP2014510151A (ja) * | 2011-04-05 | 2014-04-24 | バーテックス ファーマシューティカルズ インコーポレイテッド | Ａｔｒキナーゼ（ｔｒａｋｉｎａｓｅ）阻害剤として有用なアミノピラジン化合物 |
| WO2014093988A2 (en) | 2012-12-14 | 2014-06-19 | Phusis Therapeutics, Inc. | Methods and compositions for inhibiting cnksr1 |
-
2013
- 2013-12-16 WO PCT/US2013/075505 patent/WO2014093988A2/en not_active Ceased
- 2013-12-16 JP JP2015548050A patent/JP6357292B2/ja active Active
- 2013-12-16 EP EP13863280.7A patent/EP2931280B1/en active Active
- 2013-12-16 MX MX2015007608A patent/MX372739B/es active IP Right Grant
- 2013-12-16 CA CA2895162A patent/CA2895162C/en active Active
- 2013-12-16 MX MX2019015648A patent/MX393754B/es unknown
- 2013-12-16 US US14/649,349 patent/US9340532B2/en active Active
- 2013-12-16 AU AU2013358876A patent/AU2013358876B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016508969A5 (https=) | ||
| CN115768427B (zh) | 癌症疗法中用于靶向降解不可靶向的kras的新型小分子 | |
| JP2016513661A5 (https=) | ||
| WO2017040993A4 (en) | Small molecule inhibitors of dyrk1a and uses thereof | |
| JP2009541223A5 (https=) | ||
| JP6835472B2 (ja) | 癌の処置のための組成物 | |
| JP7319977B2 (ja) | チューブリン阻害剤 | |
| TW202014186A (zh) | 作為核轉運調節劑之化合物及其用途 | |
| MD3442972T2 (ro) | Inhibitori ai bromodomeniului | |
| AU2019366819B2 (en) | Biomarkers of MetAP2 inhibitors and applications thereof | |
| JP6357292B2 (ja) | Ｃｎｋｓｒ１を阻害するための方法及び組成物 | |
| KR20140035493A (ko) | 중수소 농축된 4-하이드록시-5-메톡시-ｎ,1-다이메틸-2-옥소-ｎ-[(4-트리플루오로-메틸)페닐]-1,2-다이하이드로퀴놀린-3-카르복사미드 | |
| Ozgur et al. | Heat shock protein 90 inhibitors in oncology | |
| JP2014530243A (ja) | Ａｒｒｙ−３８０の多形体、選択的ｈｅｒｂ２阻害剤、およびそれらを含有する薬学的組成物 | |
| WO2021018032A1 (en) | Pharmaceutical composition of mdm2 inhibitor and use thereof for preventing and/or treating disease | |
| CA2464471A1 (en) | Method of treating depression with delta receptor agonist compounds | |
| BR112012022632A2 (pt) | Medicamento compreendendo agonista de ep4 | |
| JP2019524738A (ja) | ケモカインの生物活性を中和するためのピリミジノン誘導体およびその使用 | |
| EP3296294B1 (en) | Compound for treating or preventing breast cancer | |
| WO2007132221A1 (en) | Combined anticancer pyrimidine-thiazole aurora kinase inhibitors | |
| US10173995B2 (en) | Pyridine compounds used as PI3 kinase inhibitors | |
| JP7027324B2 (ja) | 増殖性疾病の組み合せ療法 | |
| US9546159B2 (en) | N-substituted 3,4-bis (catechol) pyrrole compounds, and the preparation and use thereof in the treatment of cancer | |
| WO2019241766A1 (en) | Oligonucleotide-based proteolysis targeting chimera | |
| Kim et al. | Synthesis and structure-activity relationship studies of 1, 5-isomers of triazole-pyrrolopyrimidine as selective Janus kinase 1 (JAK1) inhibitors |